Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing (2021)
- Autores:
- Mendrone Junior, Alfredo
- Dinardo, Carla Luana
- Ferreira, Suzete Cleuza
- Nishya, Anna
- Salles, Nanci Alves
- Almeida Neto, Cesar de
- Hamasaki, Debora Toshei
- Facincani, Tila
- Alves, Lucas Bassolli de Oliveira
- Machado, Rafael Rahal Guaragna
- Araujo, Danielle Bastos
- Durigon, Edison Luiz
- Rocha, Vanderson Geraldo
- Sabino, Ester Cerdeira
- Mendrone Junior, Alfredo
- Autores USP: DURIGON, EDISON LUIZ - ICB ; ROCHA, VANDERSON GERALDO - FM ; SABINO, ESTER CERDEIRA - FM ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
- Unidades: ICB; FM
- DOI: 10.1111/trf.16268
- Assuntos: MICROBIOLOGIA; COVID-19; IMUNOENSAIO; IMUNOGLOBULINAS; ANTICORPOS; TESTES IMUNOLÓGICOS; PLASMA
- Agências de fomento:
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: 10 p., 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
MENDRONE JUNIOR, Alfredo et al. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16268. Acesso em: 18 set. 2024. -
APA
Mendrone Junior, A., Dinardo, C. L., Ferreira, S. C., Nishya, A., Salles, N. A., Almeida Neto, C. de, et al. (2021). Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, 10 . doi:10.1111/trf.16268 -
NLM
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2024 set. 18 ] Available from: https://doi.org/10.1111/trf.16268 -
Vancouver
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2024 set. 18 ] Available from: https://doi.org/10.1111/trf.16268 - Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?
- Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort
- A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
- Effectiveness of strategies to screen for blood donors with RH variants in a mixed population
Informações sobre o DOI: 10.1111/trf.16268 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
